Chairman and Managing Director-Dr.Agarwal’s group of eye hospitals and Eye Research Centre, 222, TTK Road, Alwarpet, Chennai 600018, Tamilnadu, India
Past President- International Society of Refractive Surgery (ISRS)
Secretary General- Indian Intraocular implant and Refractive Society (IIRSI)
Amar Agarwal is the pioneer of Phakonit, which is Phako with a Needle Incision Technology. This technique became popularized as Bimanual phaco, Microincision cataract surgery (MICS) or Microphaco. He was the first to remove cataracts through a 0.7 mm tip with the technique called Microphakonit. He has also discovered No anaesthesia cataract surgery and FAVIT, a new technique to remove dropped nuclei. The air pump, which was a simple idea of using an aquarium fish pump to increase the fluid into the eye in bimanual phaco and co-axial phaco has helped prevent surge. This built the basis of various techniques of forced infusion for small incision cataract surgery. He has also discovered a new refractive error called Aberropia. He has also been the first to do a combined surgery of microphakonit (700 micron cataract surgery) with a 25 gauge vitrectomy in the same patient thus having the smallest incisions possible for cataract and vitrectomy. He is also the first surgeon to implant a new mirror telescopic IOL (LMI) for patients suffering from age-related macular degeneration. He has also been the first in the world to implant a Glued IOL. He also has brought out the technique of IOL Scaffold in which a three-piece IOL is injected into an eye between the iris and the nucleus to prevent the nucleus from falling down in posterior capsular ruptures. Hypersonic vitrectomy for cases of PC rupture was first done by him and he was the principal investigator for the first hypersonic vitrectomy cases done in the world.
Pre Descemet’s Endothelial Keratoplasty or PDEK was started by Prof Agarwal. Dr Agarwal has designed a new instrument called the Trocar anterior chamber maintainer in complicated cases, which helps give infusion through the anterior chamber and works like a trocar cannula. He has also started a new technique of iris suturing called Single pass Four Throw (SFT) pupilloplasty. Subsequenly he started Pinhole pupilloplasty to treat patients with high astigmatism and higher order aberrations.
Dr. Agarwal has performed more than 200 live surgeries at various conferences. His videos have won many awards at the film festivals of ASCRS, AAO and ESCRS. He has more than 250 peer review articles in top journals and has also written more than 80 books in Ophthalmology which have been published in English, Spanish, portugese and chinese. He is the Chairman and managing director of Dr.Agarwals group of eye hospitals with 221 eye hospitals in 11 countries.
Andrew G. Lee is the Herb and Jean Lyman Centennial Chair in Ophthalmology and is the Founding Chairman of the Blanton Eye Institute, Department of Ophthalmology at Houston Methodist Hospital in Houston, Texas. He is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medicine and an adjunct professor of Ophthalmology at Baylor College of Medicine; Texas A and M College of Medicine; University of Iowa and the University of Buffalo; and Clinical Professor at the University of Texas Medical Branch (UTMB) in Galveston, Texas and the UT MD Anderson Cancer Center.
He is a graduate of the University of Virginia (UVA) undergraduate and UVA School of Medicine. He was an ophthalmology resident and chief resident at Baylor College of Medicine and a clinical neuro-ophthalmology fellow and Fight for Sight postdoctoral research fellow at the Wilmer Eye Institute, the Johns Hopkins Hospital.
Dr. Lee has served in numerous leadership roles at the American Academy of Ophthalmology (AAO) and has received the AAO Achievement Award, Senior Achievement Award, Secretariat Award (three times), and Lifetime Achievement Award. He is a past President, a past Chairman of the Board, and Senior VP for Advocacy of the North American Neuro-ophthalmology Society.
Dr. Lee has received the teaching award 15 times at 7 different academic institutions including the Osler Excellence in Teaching Award, the Baylor College of Medicine Dan B. Jones Teaching Award, University of Iowa Charles Phelps Award, the Texas A and M Mid Career Education award, the HMH Presidential Excellence in Education, and the Houston Methodist Hospital Sherilynn Gordon Memorial Leadership Award.
Dr. Lee has been the invited speaker at over 400 national and international medical meetings; has written over 600 peer-reviewed publications and 14 full textbooks; and has given 15 named lectures. His h-index is 68 and his i-10 is 367 with over 18,000 citations. He has been named one of top 30 ophthalmologists in the United States by Newsweek magazine and is the only neuro-ophthalmologist on the list.
He lives in Houston, Texas with his wife, Hilary; his two daughters (Rachael and Virginia), and his two cats (Lola and Miss Kitty).
Dr. André Maia is a Brazilian ophthalmologist specializing in clinical and surgical retina. He earned his M.D. and completed his ophthalmology residency at the Federal University of São Paulo (UNIFESP), where he also obtained a Ph.D. in Medicine (Ophthalmology) in 2003, with a thesis on retinal vein catheterization for the treatment of venous occlusions. He pursued a Retina fellowship at McGill University in Canada, under the supervision of Drs. David Chow and Michael Kapusta. Dr. Maia is currently the medical director of Retina Clinic in São Paulo and leads a specialized team focused on the diagnosis and management of complex retinal diseases. He has been an active contributor to scientific research and education in ophthalmology and has presented at multiple national and international congresses. He is fluent in Portuguese and English, and has working knowledge of Spanish and French. His expertise bridges advanced surgical techniques and evidence-based clinical practice.
Dr Barbara Parolini was born in Verona, Italy, on April 17th, 1968.
She is an ophthalmic surgeon who exercises her practice, mainly in Italy, since 1997. She graduated in Italy from Medical School with laude in 1993 and obtained the diploma in Ophthalmology in 1997.
She has undertaken a postdoctoral fellowship at UCSF (San Francisco, USA) and at UMDNJ (Newark, USA), on retinal pigment epithelium transplantation in 1994-1995 and 1997-1998.
She has been Director of Clinical Studies for FDA for the Medjet Company, in Edison USA, in 1997-1998.
She works as consultant in foreign countries.
Her expertise are:
She has operated about 15000 cases
She has published
She is teacher at:
She has performed live surgery in Italy and abroad. Of note, at:
She serves as Reviewer of the following peer reviewed-journals:
Approved at the exam of the Italian Ministry as University Associate Professor
Organiser of 3 international meetings, Retinitaly in 2015, 2016, 2017
Since 2016, VicePresident of the European VitreoRetina Society
Since 2020 Board member or Retina World Congress and leading the RWC- Global Research Group
She obtained a patent of a model of macular buckle and a kit for episcleral surgery.
Member of the following societies: GIVRE, SOI, AIMO, AAO, ASRS, EVRS
16 June 2023 Awarded with the DOC Retina Science Award
Professor Bruce Allan qualified in medicine from Cambridge in 1985, and was appointed as a Consultant Surgeon at Moorfields in 1998 after advanced specialist training in the UK, South Africa, and Australia. He was Training Director for the Corneal Service at Moorfields for over 10 years, and Service Director for Refractive Surgery from 2012 to 2019. He is currently chairing the Royal College of Ophthalmologists Refractive Surgery Standards Working Group and the European Society of Cataract and Refractive Surgeons (ESCRS) Digital Health Special Interest Group. He is an ESCRS Council and EU Cornea board member.
He and his wife, Consultant Psychiatrist Dr Maria Teresa Casasus Borrell, live in North London with regular visits from their 3 daughters, Saskia, Sofia and Silvia. Outside work, He is a keen football fan and sailor.
Professional activities include:
Current research interests include:
Burkhard Dick was born in a small town by the name of Brake in Northern Germany. After graduating from the local high school, he served for two years as a medical officer with Germany’s NATO forces. He attended medical school at the University of Giessen, a city with a strong American presence during the Cold War, where he graduated in 1990, a year that saw German unification and changed Giessen’s location where he began his residency in ophthalmology from bordertown at the edge of the Iron Curtain to suddenly being in the country’s geographical centre.
Dick became head physician at the University Eye Hospital in 1995 before he moved to the Eye Hospital of the University of Mainz which bears the name of that city’s greatest son, Johannes Gutenberg. Here he specialized in refractive and cataract surgery and became head of the hospital’s Refractive Surgical Eye CareCenter in 1997. Shortly after becoming a clinical professor in Mainz, the University of Bochumoffered offered Burkhard Dick the position of head and director of its eye clinic and eye research centre which he accepted in 2006. Since then, the Bochum University Eye Clinic has become an internationally renowned institution with a constant output of highly ranked research papers and clinical studies, most of them published in the Journal of Cataract and Refractive Surgery and the Journal of Refractive Surgery.
Burkhard Dick became one of the first ophthalmic surgeons in Europe to use a femtosecond laser in cataract surgery; to date almost 12,000 eyes have been operated with that technology in Bochum.
For his pioneering work, he has been awarded a number of honours like the Choyce Medal of the British Ophthalmological Society, the Gold Medal Award of the Australian Society for Cataract and Refractive Surgery, the Waring Medal of the Journal of Refractive Surgery and, most recently, the Visionary Award of the American-European Congress of Ophthalmic Surgery (AECOS).
He currently serves as the Treasurer of the German Society of Cataract, Refractive and Interventional Surgery (DGII) after being President of the DGII for four years (2016-2020). He is a regular lecturer at international meetings like the AAO, DOG, DOC, DGII, ESCRS, APAO and ASCRS and has instructed fellows in the University Eye Hospital Bochum from 44 different countries in state-of-the-art cataract, refractive, glaucoma and vitreoretinal surgery.
Eye surgeon specializing inVitreoretinal Surgery, with over 35 years of experience. He currently works at the Miranza Group Institute of Ocular Microsurgery (IMO) in Barcelona and at Miranza Andorra. He is a founding member of the IMO and has worked at institutions such as the General Hospital Valle Hebrón and the General Hospital of Catalonia. He is an expert in pathologies such as high myopia, retinal detachment, severe ocular trauma, and diabetic retinopathy. He introduced innovative techniques such as Macular Translocation and Macular Buckling to Spain. He is an associate professor on the Master’s Degree in Retina and Vitreous at the Autonomous University of Barcelona and a part-time lecturer on retina modules at the European School for Advanced Studies in Ophthalmology (ESASO).
Dr. McCabe serves as Chief Medical Officer at Eye Health America™. She is one of the foremost eye surgeons today, specializing in bladeless laser cataract surgery and LASIK at The Eye Associates in Sarasota, Florida. Dr. McCabe has performed over 45,000 cataract surgeries and more than 17,000 LASIK procedures. She has a keen interest in advancing the field of ophthalmology and has participated in numerous clinical trials, including innovations in intraocular lenses, perioperative medications, medications and devices to treat glaucoma, dry eye treatments and presbyopia correction.
Dr. McCabe continues to receive many prestigious and esteemed awards for her work in Ophthalmology, including being named a Castle Connolly Top Doctor – 2015, 2016, 2017, 2018, 2019 and 2020 for Ophthalmology. Castle Connolly also selected her for the first-ever Exceptional Women In Medicine Award for 2017, 2018, 2019 and in 2020. She was named to the OSN Premier Surgeon 300 List, and the Premier Surgeon 250 List of Leading Innovators in Premium IOL Cataract Surgery. She was also chosen a LASERVISION Top 100 LASIK Surgeon, elected President of CEDARS/ASPEN-2017, has received the American Academy Achievement Award, is the Vice President and incoming President of the Outpatient Ophthalmic Surgery Society, and serves on numerous editorial and subspecialty boards and committees. She is passionate about giving back to her local community, profession and globally and participates in charitable giving and volunteer efforts both at home and abroad. She is a board member of several charitable foundations in ophthalmology, including One World Global Health/Vision Quest, OOSS Gives, and others.
Dr. McCabe received her medical degree from the Medical College of Wisconsin and received her residency training at the prestigious Bascom Palmer Eye Institute at the University of Miami’s School of Medicine. She continues to share her expertise by publishing articles and book chapters as well as lecturing at national and international ophthalmological seminars.
Occupational field Full Professor of Ophthalmology and Chairman of Eye Clinic – Department of Medical Surgical Sciences and Health – University of Trieste, Italy Italian Medical Licence n. 3399 Work experience Date Position held Main activities and responsibilities Date October 2019 onwards Full Professor of Ophthalmology – Eye Clinic – University of Trieste – Italy Anterior and posterior segment surgeon. 1st November 2011 onwards Position held Chairman of University Eye Clinic – Department of Medical Surgical Sciences and Health – University of Trieste, Italy and Professor of Ophthalmology 2/11 – Curriculum vitae di Tognetto Daniele Europass: http://europass.cedefop.europa.eu © European Union, 2002-2010 24082010 Main activities and responsibilities Anterior and posterior segment surgeon (surgery from 1st Jan 1992 to present): More than 20.000 surgical procedures. (Cataract, retina, cornea and glaucoma surgery). Director of the Eye Clinic. Tutor for surgeons in training. Head of Ophthalmology Course in the Degree Course in Medicine and Surgery at the University of Trieste Head of Residency Program in Ophthalmology at the University of Trieste.
Heads the Cataract and Glaucoma departments at Megur Eye Care Centre, Bidar Karnataka India.
Specialises in Complex Cataract Surgeries. He is committed to teaching surgery through his personal Youtube Channel.
He has more than 200 presentations at various national and international meetings. He is a reviewer for the Indian Journal Of Ophthalmology. He has won many national & international awards for scientific Papers and Videos.
Born in Paris, in 1957
Medical studies in Paris. Residency (Ophthalmology) in Toulouse. Fellowship (PO&S) in Toulouse and Nantes (Pr Quere). Private practice in Toulouse and consultant surgeon in Toulouse Universitary Hospital from 1992, exclusively surgical pediatric ophthalmology and strabismology. Teacher in Toulouse Orthoptic school, and French Universitary Diploma of Strabology and Pediatric ophthalmology.
Active member of French Society of Ophthalmology. Co-author of both Pediatric ophthalmology (2017) and Strabismology (2013) annual books of the society.
Former vice president of French association of PO&S. (AFSOP) and of European Strabismological Association.
Member of AAPOS, ISA, and WSPOS. Member of IPOSC for AFSOP representation. Local organiser of the last ESA/ISA meeting in my hometown, Toulouse in 2024.
Field of works and publications since 1990: Deprivation amblyopia, Infantile cataracts, Infantile Strabismus, strabismus surgery in general, and more precisely in Infantile strabismus, Botulinum Toxin, in high Myopia, Oblique muscle surgery. Recent works on global scoring of IXT and surgery of exotropia with combined recess and resect on same muscle.
… and still time for hobbies that I share with my 3 boys, 5 grand-children and my friends: music, mountain climbing, sailing, hiking.
Renowned ophthalmologist and academic leader with over three decades of experience in ocular surface diseases, dry eye, and inflammation. Currently serving as Chair of Ophthalmology at Universidad Complutense de Madrid and Head of the Ocular Surface and Inflammation Unit at Hospital Clínico San Carlos. Internationally recognized for contributions to research, education, and clinical practice in ophthalmology.
Fabio Patelli, M.D. is the director of vitreoretinal service department of Ophthalmology at the ASST Santi Paolo e Carlo Hospital, University of Milan. He graduated magna cum laude at the University of Milan and specialized in Ophthalmology magna cum laude at the San Raffaele Hospital, University of Milan.
He did a brief fellowship in Boston at the Massachusetts Eye and Ear Infirmary Hospital with Prof Donald J D’Amico and in New York at the Columbia University with Prof. Stanley Chang.
His main field of interest since he was a resident is vitreoretinal surgery. He is author of many papers and Editor of THREE books about vitreoretinal surgery (Springer ed.).
Complementing his research endeavors, Dr. Patelli serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences.
He is reviewer of several journal as “Retina”, “European Journal of Ophthalmology”, “Graefe’s Archive for clinical and experimental Ophthalmology” and he is part of the editorial board of “Journal of vitreoretinal diseases”.
He is one of the few surgeons worldwide who implanted the Argus II artificial retina in blind patients.
He is member of many ophthalmological societies such as SILO (Italian Society Laser in Ophthalmology), SOI (Italian Society of Ophthalmology), S.I.E.T.O. (Italian Society of Ocular Trauma), G.I.V.R.E. (Italian Group of vitreoretinal surgery), ASRS (American Society of Retina Specialists), EVRS (European Vitreo-Retinal Society), PAAO (Pan American Association of Ophthalmology), AAO (American Academy of Ophthalmology), Euretina (European retina society) Retina society.
Dr. Gerardo López Oseguera is an ophthalmologist and biomedical engineer specialized in anterior segment and retina surgery. He completed fellowships at the Instituto de Microcirugía Ocular (IMO) in Barcelona and holds an MBA in Health Innovation. Founder of Eyedictive, he focuses on developing novel surgical and diagnostic technologies, including the Oseguera Ring—a scleral fixation device for intraocular lens stabilization. His work bridges clinical practice and medical device innovation, with ongoing collaborations in preclinical validation and global ophthalmic research initiatives.
Giampaolo Gini is a general ophthalmic surgeon with a specific interest in retina.
He has been performing vitreo retinal surgery since 1990.
He is currently a substantive Consultant at University Hospitals Sussex NHS Trust with a specific role as vitreo-retinal surgeon while still maintaining an active private practice both in Italy and in the UK.
In the past he has covered several Consultant posts both for the Italian (SSN) as well as the British (NHS) National Health systems.
He has a considerable surgical experience with roughly 25.000 procedures on the anterior segment and 18.000 on the posterior segment of the eye. Because of this he has always been employed to deal with the more challenging cases on theatre lists.
Through the years he has developed a special interest in diabetes and ocular trauma surgery.
He is also known internationally as being one of the first surgeons to challenge the results of the Early Vitrectomy Study for the treatment of endophthalmitis. The paper published in 2006 (Vitrectomy for Endophthalmitis; Kuhn and Gini in “Ophthalmology”) helped pave the way for others to follow with their own experiences.
Dr Gini is an internationally recognised clinician, surgeon and educator.
He has received numerous international awards, among which the coveted Italian Ophthalmological Society Award (twice), the Royal College of Ophthalmologists’ Treacher-Collins Award and the American Society of Retina Specialists Reis-Buckler Award (twice).
He has frequently been involved in “live surgery” meetings both at home and abroad.
As a lecturer he has accumulated over 900 hours of activity in meetings in every part of the World.
He is an Associate Professor of Ophthalmology at Maimonides University Medical School (Buenos Aires, Argentina) and Visiting Professor of Ophthalmology at Yale University (New Haven, Connecticut, USA).
He has served as Board Member and Secretary of the European Vitreo Retinal Society of which he is currently President.
He has been named Liaison Officer to Europe for the American Society of Retina Specialists (ASRS) and is a Board Member of the Italian Association of Ophthalmologists (AIMO).
He has been a Faculty member of the European Vitreo Retinal Training School (Bremen), since its inception in 2001. This has resulted in contributing to the the training of over 1000 vitreo-retinal specialists.
Ever since his election to President of the European Vitreo Retinal Society (EVRS) he has also been actively involved in organising the Scientific Program of the Society’s Annual meeting (2017 Florence, 2018 Prague, 2019 Lisbon and the upcoming 2024 meeting in Budapest).
Particularly dear to him the invitation to deliver the Opening Lecture at the newly formed BEECS (British Emergency Eye Care Society) at Birmingham University in 2017 and the 2018 invitation to the annual meeting of the American Academy of Ophthalmology to lecture on the treatment of endophthalmitis.
He is a reviewer for multiple peer-reviewed scientific Journals.
He has contributed with a chapter in the book on Pediatric Vitreo Retinal Surgery (Springer Verlag) edited by Prof. Sengul Ozdek. He has also written several chapters and co-edited another book by Springer: Practical Manual of Vitreo Retinal Surgery.
Prof. Dua is a specialist in surgical and medical treatments of cataract, refractive errors, cornea, including corneal transplants and Stem cells, and ocular surface diseases. He has extensive experience and knowledge of a variety of eye conditions including dry eyes, keratoconus, cataracts, conjunctivitis and ulcers. As an Ophthalmologist, Prof. Dua is a Global Leader who has made many notable and innovative contributions in his medical field.
Patience, compassion and understanding is at the core of Prof. Dua’s care. He takes time listening to the needs and concerns of his patients and offers clear communication in English, Hindi, Urdu, Punjabi and Marathi. Above all else, Prof. Dua’s medical and surgical treatments are second to none.
Training and Experience
After completing basic medical qualifications, Prof. Dua trained as a specialist in eye diseases (Ophthalmology) in India, England, Scotland and USA. He then undertook advanced Cornea and External Eye Disease training as a Fellow, at the Wills Eye Hospital, Philadelphia.
Prof. Dua has over 40 years’ experience in the diagnosis, medical and surgical treatment of eye diseases. He has served as a Consultant Ophthalmologist and Professor of Ophthalmology, Nottingham, since 1994. He specialises in the treatment of simple to complex cases of eye diseases affecting the front half of the eye.
Dr Mansouri is the Executive Vice President of the World Glaucoma Association.
He is also the Chief Medical Officer of iStar Medical, Belgium and Implandata GmbH, Germany. Dr Mansouri is the co-founder and President of the Swiss Glaucoma Research Foundation.
Dr Mansouri is a glaucoma specialist and a clinician-scientist. His academic accomplishments include over 180 peer-reviewed journal articles with an h-index of 63 (google scholar).
Since 2020, he has been continually ranked as one of the Top 20 Glaucoma Specialists in the world (Expertscape.com). He is on the editorial boards of the “Journal of Glaucoma” and the “Revista Brasileira de Oftalmologia”, is an associate editor of “Acta Ophthalmologica”, and is a contributing editor to the “International Glaucoma Review”. He is co-editor of the textbook “The Science of Glaucoma Management” and co-author of 12 textbook chapters.
In 2012, Dr Mansouri was the first ophthalmologist to give a TEDx talk, with the aim of improving glaucoma awareness.
Dr Mansouri’s clinical and scientific expertise has resulted in him being selected by the journal “The Ophthalmologist” as a Top 100 Ophthalmologist in the world (Power List 2024). Previously, he had been ranked twice in the top 40 under 40 power list by the journal “The Ophthalmologist”. He has also been chosen as a top ophthalmic innovator by the journal CRST Europe (Nov 2022). He has been featured on BBC World (“Secrets of the Superagers/Senses”).
He directs an active fellowship program which trains candidates from all continents and is a host to ICO fellows from developing countries.
Dr Mansouri has been the recipient of several international awards, including the prestigious Boberg-Ans from the Danish Ophthalmological Society, the MGS Alcon International Lecture, the American Academy of Ophthalmology (AAO) Achievement Award and AAO International Scholar Award, among others.
Dr. Kaweh Mansouri is a pioneer and expert in the use of intraocular pressure monitoring technology and a pioneer in MIGS. His research activities are focused on advancing 24-h IOP monitoring, as well as the development of new technologies in the field of glaucoma imaging and surgery.
Mr Leon Au is a Consultant Ophthalmic Surgeon specialising in glaucoma and cornea. He graduated from the University of Nottingham in 1998 with an ophthalmology prize of the year. He completed 8 years of general ophthalmology training in Nottingham and Manchester before undertaking separate subspecialty training fellowships in cornea, glaucoma and refractive surgery. He has been a dual-specialty consultant in the Manchester Royal Eye Hospital since February 2009. He is an international leader in the field of innovative glaucoma surgeries and is involved in many of the clinical trials
Dr. Livia Lumbroso-Le Rouic is an ophthalmologist specializing in ocular oncology. She serves as a senior physician at the Institut Curie in Paris, one of Europe’s leading cancer centers. Dr. Lumbroso-Le Rouic focuses primarily on the diagnosis and treatment of eye tumors, including uveal melanoma and retinoblastoma. Her work combines clinical care with research, aiming to improve therapeutic outcomes and preserve vision in patients with ocular cancers. She is also involved in academic teaching and has contributed to numerous scientific publications in her field.
Luís Abegão Pinto is the Head of the Glaucoma Clinic of the Department of Ophthalmology of Portugal’s largest Hospital (Hospital Santa Maria). He serves as Assistant Professor of Ophthalmology at the Faculty of Medicine of Lisbon University, Portugal. His main areas of interest are Glaucoma Surgery, Artificial Intelligence and screening.
He serves in the Executive Board of the European Glaucoma Society (EGS) since 2018 and he is currently the EGS Vice President. Moreover, he is co-chair of the EGS TaskForce on Glaucoma Surgery, co-editing the new “Guides on Innovations in Glaucoma Surgery”
He has authored or co-authored 105 indexed, peer-reviewed papers in Glaucoma. He is actively engaged in a number of scientific ophthalmological societies, including the EGS and EVER, having chaired or co-chaired a number of courses in international Ophthalmology societies’ meetings.
Professor (Dr.) Mahipal. S. Sachdev, Chairman & Medical Director of Centre for Sight is a renowned ophthalmic Surgeon who is recognized for his expertise in the area of Cataract, Refractive & Corneal Surgery, both nationally and internationally. He was honored with Padmashri award on January 26, 2007. In the year 2017, he attained Professorship in Ophthalmology & in year 2020 has been elected as President of All India Ophthalmological Society. He is widely credited to be pioneer in India in propagating the technique of Phacoemulsification for cataract surgery and Lasik Laser for removal of glasses.
In 1996, Professor (Dr.) Mahipal Sachdev stepped out of AIIMS with a dream of creating a world class eye hospital. “Centre for Sight” is an outcome of that.
Professor (Dr.) Mahipal is a visionary and leader. He has always been the torchbearer in the field of eye care pioneering several procedures including laser assisted blade less surgery for cataract and Lasik. Prof. Mahipal learned about “Phaco” (Stich less micro incision cataract surgery) while pursuing his fellowship in United States. He knew it was next big thing in ophthalmology. Prof. Mahipal was among the first to introduce Lasik and Phakic IOLs & Femtosecond laser technology for lasik. Prof. Mahipal also has pioneered blade free Femtocatarct technology in India.
He has authored over 5 books on cataract & Refractive surgery including the first book on phaco by an Indian Ophthalmologist. These books are today referred to by every budding Ophthalmologist. Prof. Mahipal is an active contributor of articles on eye health in mass media for the benefit of the general public also.
He has been recognized globally with fellowships and scholarships from the “Fifth International Symposium on Immunopathology”- Japan, “International Society of Eye Research”, “Research to Prevent Blindness”, New York, “Fisons award by the Contact Lens Association of Ophthalmologists”, USA amongst others. In India he has won the “A C Aggrawal Memorial Trophy”, “Col. Ranagachary Certificate”, “Krishna Sohan Singh Trophy”, “Dr Ishwar Chand Silver Jubilee Award” to name a few. Prof. Mahipal Sachdev has recently been awarded “Dr. S.N. Mitter Oration award” in DOS conference held in April 2017”. Prof. Mahipal has also received “Life Time Achievement Award- Ophthalmology” at Times Health Care Achievers program held in Delhi. To add on Prof. Mahipal was honored with a Gold Medal in KOSCON conference 2017 in Bengaluru.
Prof. Mahipal is an actively involved in Research & Development, he has been instrumental in the Development of the ELITA Femtosecond laser by J&J. He was the PI of the First-in-man clinical trials for the ELITA. He is also the first person in the world to perform the Flap as well as the Lenticule extraction procedure (SILK) on the ELITA platform.
Prof. (Dr.) Mahipal S. Sachdev was honored with Padamshree Prof. Dr. TP Lahane Award Award at MOSCON 2022. Further, he was honored with Dr. Hari Mohan Oration 2022 in 73rd DOS Conference at New Delhi. He is presently also member of the Global Advisory Board, J & J. Prof. Sachdev was felicitated with the APACRS Certified Educator (A.C.E) award, and was also awarded appreciation as the IIRSI representative, at the APACRS 2023, Singapore.
Prof. (Dr.) Mahipal S. Sachdev was awarded Hero of Ophthalmology award in KSOS 2023 at Thrissur, Kerala. Further, he was honored with Honorary Doctorate (D.Sc. Honoris Causa) at 19th Annual Convocation of the University held on 08 Dec 23 (Friday) at Amity University, Uttar Pradesh (AUUP), Noida.
Prof. (Dr.) Mahipal S. Sachdev has been conferred with the prestigious “AIOS – Dr. LP Agarwal Endowment Lecture 2024 and Achievement Award at AIOC 2024 held from 14 -18 Mar 24 at Kolkata, West Bengal and “ISCKRS Refractive Oration Award at ISCKRS Annual Conference held from 02 -04 Aug 2024 at New Delhi.
Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Asu Biswas Kanika Biswas Oration Award at Conference held on 11 Aug 2024 at Trenetralaya, Kolkata, West Bengal. Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Legend in Ophthalmology Award at Conference held from 03 -05 Jan 2025 at MM Joshi Eye Institute, Hubli, Karnataka. Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “RP Centre Oration Award on 58TH RP Centre Foundation Day on 10 Mar 2025 at Delhi. Recentley, Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Senior Achievement Award at AIOS APAO Conference 2025 on 05 Apr 25 at Delhi.
Prof. (Dr.) Mahipal S. Sachdev is a rare combination of a brilliant surgeon, an entrepreneur and above all, a compassionate human being. He has ensured that the Indian Flag remains flying high in the domain of eye care and that the patients in India have access to the best and the latest when it comes to treating their eyes in line with his own mission statement “…. every eye deserves the best”.
Dr Ramesh Kekunnaya is the Network Director – Technology Innovation at LVPEI. The other major portfolios that he is handling include Director of the Child Sight Institute, Director of Centre for Technology Innovation, and Head – Jasti V Ramanamma Children’s Eye Care Centre at LVPEI. Dr Kekunnaya is also an Executive Bureau Director of the World Society for Paediatric Ophthalmology and Strabismus (WSPOS), Founder Executive Bureau member of Paediatric Ophthalmology and Strabismus Network (POSN) of India, and an Administrative Council Member of the International Strabismological Association (ISA).
Dr Kekunnaya received his basic medical training from the Karnataka Medical College, Hubli, and specialized in ophthalmology from the Government Medical College, Mysore. He completed a fellowship in Paediatric and Neuro Ophthalmology, Strabismus and Comprehensive Ophthalmology at LVPEI, followed by a Paediatric Ophthalmology and Strabismus Fellowship (AAPOS accredited) at the Jules Stein Eye Institute, University of California, USA. His core clinical interests include simple and complex strabismus in adults and children (squint), childhood cataract, vision development, myopia, amblyopia (lazy eye) and neuro-ophthalmological disorders in children.
He has been honoured with Achievement Awards from the American Academy of Ophthalmology (AAO) and Asia Pacific Academy of Ophthalmology. Dr Kekunnaya is also the recipient of the International Scholar Award and International Education Award from AAO, and Honor Award from the American Association for Pediatric Ophthalmology and Strabismus.
Dr Kekunnaya has authored over 150 publications in peer-reviewed journals in addition to having written over 25 text book chapters. He is the Paediatric Ophthalmology and Strabismus Section Editor for the British Journal of Ophthalmology, the Current Eye Research, and the BMJ Open Ophthalmology. He has presented widely, is invited as keynote speakers at both national and global levels, and is passionate about teaching.
Rania Maklad is the CEO and Co-Founder of OCUWELL, a health technology company focused on improving eye care through innovation and accessibility. With a background in healthcare management and digital innovation, Rania has played a key role in shaping OCUWELL’s goal of making vision screening and eye health monitoring more proactive and personalized.
Under her leadership, OCUWELL has grown from a simple idea into a developing startup, known for its AI-powered diagnostics and eye health solutions. Rania’s vision has helped position OCUWELL as an emerging player in the region’s health-tech sector, collaborating with clinics, research institutions, and corporate wellness programs.
Rania is also passionate about promoting inclusive innovation and supporting women’s involvement in technology, encouraging others in the Middle East to explore how digital solutions can enhance quality of life.
Consultant Cornea and Refractive surgery Clinical and translational Scientist, Narayana Nethralaya, Bangalore, INDIA GROW laboratories Faculty, Dept. of Ophthalmology, Univ. Maastricht.
Prof. Dr. Rohit Shetty is the Vice Chairman of Narayana Nethralaya Eye Institute. He is a Professor at Sri Devaraj Urs Medical College, India and an Adjunct Associate Professor at MS Ramaiah Medical College, Bangalore and is an Affiliate Associate Professor and PhD guide at the Maastricht University in the Netherlands. Prof. Dr. Rohit Shetty has over 200 Publication in peer reviewed indexed Journals. He is a Corneal Refractive Surgeon at Narayana Nethralaya Eye Institute, Bangalore, India. His other areas of work include Neuro-ophthalmology electrophysiology.
Prof. Dr. Rohit Shetty defended his PhD from Maastricht University, Netherlandson Understanding the Clinical, Immunological and Genetic Molecular Mechanism of Keratoconus. He has a special interest in the management of Keratoconus, tear film abnormalities and biomarkers. He has introduced cutting edge technology at Narayana Nethralaya and spearheads treatment for challenging eye disorders.
In the 2015 annual conference of the All India Ophthalmological Society, Dr. Rohit Shetty won the prestigious Col. Rangachari award for the overall best paper of the conference for his work on “Is Inflammation Driving Keratoconus? – A Holistic Study Of Molecular Pathways”.
The American Academy of Ophthalmology recently conferred an achievement award to Dr. Rohit Shetty for the distinguished services he has rendered over the years to the programs of the society.
Honorary Doctorates Fellowships:
Stefano Barabino is Head of the Ocular Surface & Dry Eye Center at the Sacco Hospital, Milan University, Italy. He received his medical doctor degree from Genoa University in 1998, completed his residency in Ophthalmology in 2002, and received his Ph.D. degree in Immunology in 2005. Dr. Barabino completed a two-year fellowship at Harvard University, in Boston, USA. As specialist in dry eye and ocular surface diseases, he has published more than 200 scientific articles in Italian and International scientific journals. He is an active member of several European and International professional societies, President of the Italian Society of Ocular Surface, board member of Ocular Immunology & Inflammation, Eye & Contact Lens, The Ocular Surface, BMC Ophthalmology, Current Eye Research, TVST.
Dr. Barabino has been an active member of the Tear Film & Ocular Surface Society (TFOS) since its inception in 2000 and founding member of the European Dry Eye Society (EUDES).
Tamer Mahmoud, MD, PhD is a professor of Ophthalmology at Oakland University William Beaumont School of Medicine and the director of the vitreoretinal fellowship at Associated Retinal Consultants. He moved from North Carolina in 2017 where he was the program director of the vitreoretinal surgery fellowship at the Duke University Eye center and a tenured associate professor at Duke. He has developed many surgical techniques over the years with his fellows including the use of subretinal air to displace submacular hemorrhage in 2013 and developed and performed the first human autologous retinal transplantation in 2015. He also introduced chandelier buckles to the United States and in 2017, developed the ILM retracting door technique for macular holes. The nano subretinal gateway device was developed in 2019 to access the subretinal space without PPV to displace subretinal hemorrhage, but also for injection of gene therapy, drugs, removal of PFO and tumor biopsy. In 2022, the concept of using the epiretinal membrane to close large macular holes was introduced in cases of combined large holes with membranes. In 2023, he developed and performed the first combined amniotic and autologous retinal transplant for large refractory myopic macular holes with some atrophy. For the last few years, Dr. Mahmoud has focused on running global studies to treat macular holes by working with surgeons around the world to develop guidelines to treat challenging holes using many techniques that have been developed over the years.
Dr. Mahmoud graduated Valedictorian from Ainshams University, finished his internship, residency and vitreoretinal fellowship at the Duke University Eye Center. He is a member of the American Academy of Ophthalmology (AAO), the Association of Research in Vision and Ophthalmology (ARVO), the American Society of Retina Specialists, the Club Jules Gonin, the Macula Society, the Retina Society, The Vitbuckle society, and the United States Masters Swimming Association. He is a reviewer for many Ophthalmology journals and a principal investigator on many clinical trials sponsored by the industry and the National Eye Institute. He has been invited as a guest speaker all over the world. Dr. Mahmoud is certified by the American Board of Ophthalmology and is licensed in the states of California, Michigan, and North Carolina.
Dr. Mahmoud received the Edward K. Isbey, Jr., M.D. Resident Award for “Excellence in Clinical Care, Ethics, and Research” from the Duke Eye Center, the Retina Research Foundation/”Joseph M. and Eula C. Lawrence” award from ARVO, the “Senior Honor Award” and the “Presidential Honor Award” from the American Society of Retina Specialists, the “Achievement Award” from the AAO, the prestigious Robert A. Machemer research award from the Duke Eye Center, the “Distinguished Teacher of the Year Award” from the Kresge Eye Institute and the “Golden Globe Award” for residents’ education from the Duke Eye Center.
Dr. Mahmoud has been on the list of Best Doctors in America since 2009 and Castle Connolly Top Doctors in Ophthalmology. He was the director of the Vitreoretinal Surgery Fellowship at the Kresge Eye Institute in Michigan before moving back to Duke in 2011 to join the retina faculty. Wayne State University-Kresge Eye Institute established the “Tamer H. Mahmoud, MD endowed fellowship research award” in 2012. This award is bestowed yearly to the fellow presenting the best paper.
Dr. Mahmoud is a founder of the Duke Surgical Rounds Courses launched at national and international conferences in 2013, and co-founder of the Duke fellows advanced vitreous surgery course (fAVS). He served on the national Therapeutic Safety Committee (TSC) for monitoring of drugs and devices and founded the North Carolina Retina Club (NCRC) in 2012 to allow interaction and collaboration between retina specialists in the state of North Carolina.
Founder, CataractCoach.com
The world’s largest cataract surgery teaching website with 1850+ videos, 16 million views, 52000 subscribers, and a new video every day.
Academic Appointment:
Honors:
Moreover, Dr. Uday Devgan is the winner of the Ibn A Haytham Medal Award in the 10th EPOMEC 2023.
Dr. Oshima graduated from Osaka University Medical School and completed his residency and fellowship in vitreoretinal surgery at Osaka University Hospital under the mentorship of the late Dr. Yasuo Tano. After serving for over a decade as an Associate Professor at Osaka University, he is now the Founder and Director of the Seiyukai Medical Corporation, which operates three specialized centers for vitreoretinal and cataract surgery in Osaka, Japan. Collectively, these centers perform more than 5,000 surgical cases annually.
Dr. Oshima is internationally recognized for his pioneering work in developing the 27-gauge vitrectomy system, which has significantly advanced minimally invasive retinal surgery. He is a prolific author of scientific papers published in leading journals such as Ophthalmology, American Journal of Ophthalmology (AJO), and British Journal of Ophthalmology (BJO).
A sought-after speaker, Dr. Oshima has delivered numerous invited lectures across Asia, Europe, and the United States, and has performed live surgical demonstrations at major international meetings including the Frankfurt Retina Meeting, Floretina, and the Cairo Retina Meeting.
He serves on the Editorial Board of Retina Today and holds memberships in several prestigious ophthalmologic societies, including the American Academy of Ophthalmology (AAO), the American Society of Cataract and Refractive Surgery (ASCRS), and currently serves as the Liaison for International Affairs for the American Society of Retina Specialists (ASRS).
In recognition of his contributions to the field, Dr. Oshima has received numerous honors, including:
Sign up now to our newsletter
